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BACKGROUND: This paper reviews recent literature employing Artificial Intelligence/Machine Learning (AI/ML) methods for
diagnostic evaluation of head and neck cancers (HNC) using automated image analysis.
METHODS: Electronic database searches using MEDLINE via OVID, EMBASE and Google Scholar were conducted to retrieve articles
using AI/ML for diagnostic evaluation of HNC (2009–2020). No restrictions were placed on the AI/ML method or imaging
modality used.
RESULTS: In total, 32 articles were identified. HNC sites included oral cavity (n= 16), nasopharynx (n= 3), oropharynx (n= 3), larynx
(n= 2), salivary glands (n= 2), sinonasal (n= 1) and in five studies multiple sites were studied. Imaging modalities included
histological (n= 9), radiological (n= 8), hyperspectral (n= 6), endoscopic/clinical (n= 5), infrared thermal (n= 1) and optical (n=
1). Clinicopathologic/genomic data were used in two studies. Traditional ML methods were employed in 22 studies (69%), deep
learning (DL) in eight studies (25%) and a combination of these methods in two studies (6%).
CONCLUSIONS: There is an increasing volume of studies exploring the role of AI/ML to aid HNC detection using a range of imaging
modalities. These methods can achieve high degrees of accuracy that can exceed the abilities of human judgement in making data
predictions. Large-scale multi-centric prospective studies are required to aid deployment into clinical practice.
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BACKGROUND
Head and neck cancers: incidence and diagnosis
Head and neck cancers (HNC) comprise a heterogeneous group of
cancers, most commonly squamous cell carcinomas (SCC), that
typically arise from the epithelial lining of the oral cavity, sinonasal
tract, pharynx, larynx and salivary glands.1 Most HNC are already at
an advanced stage when diagnosed, which significantly reduces
the survival rate, even after curative treatment.2 Major risk factors
include tobacco smoking/chewing,3 excessive alcohol consump-
tion,4 areca (betel) nut, paan masala (Gutkha),5 gamma and
ultraviolet radiation, overexposure to sunlight, a family history of
cancer and increasing age.6 The role of human papillomavirus
(HPV)7 and Epstein–Barr virus (EBV) has also been implicated in
the development of oropharyngeal and nasopharyngeal SCC.3,8
The global incidence of HNC continues to rise9,10 with more than
half a million cases annually11 and ~12,000 new cases in the UK
each year, an increase of 20% in the last decade.12 Prognosis
remains poor, with a 28–67% chance of survival at five years,
depending upon the stage at presentation.12
Public health screening/awareness programmes, withdrawal of
environmental carcinogens and early detection of precancerous
lesions remain the focus for primary and secondary prevention.3
However, early detection of some HNC can be difficult due to vague
histories and indistinctive diagnostic features. Conventional diagnosis
of HNC is based on histopathological evaluation of tissue sections
from biopsies or surgical resections, in addition to clinical and
radiological examinations. These methods can be time-consuming
and are prone to errors in observation or variations in interpreta-
tion,13–15 which can result in inconsistencies in cancer grading and
prognostication.16 Consequently, this can cause delays and/or
inaccuracies in diagnosis, which can have significant implications
on patient management and survival. Indeed, improvements in HNC
prediction accuracy and disease outcomes could greatly assist
healthcare professionals in the early detection and planning of
patient-specific optimal treatments to reduce the disease burden.
Artificial intelligence: machine learning and medical image
analysis
Recent technological advancements in Artificial Intelligence (AI)
algorithms, computer hardware and big medical imaging datasets
have enabled computer scientists and healthcare researchers to
collaborate closely to improve consistency in cancer risk
stratification over the use of multi-factor analysis, conventional
logistic regression and Cox analyses.17
The recent advent of Machine Learning (ML) has seen a surge of
interest with the exponential growth of evidence to support its
wide applications in a range of cancers.18–24 ML is a branch of AI
that uses computational methods to detect patterns, gather
insight and make predictions about new data by using historical
information that has been ‘learnt’. As the volume of training data
increases, ML algorithms can produce more accurate and efficient
predictions.25 Deep learning (DL) is a subfield of ML in which
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algorithms are structured to create artificial neural networks with
multiple hidden layers. These methods have also gained
significant popularity in recent years due to their achieving
relatively high accuracy of prediction.
Much of the recent focus in cancer diagnostics has centred on
digital image analysis and processing, which involves extraction of
meaningful information from images to enable delineation of
features of clinical interest (segmentation) or description of labels
(classification).26,27 A number of ad hoc (or hand-crafted) feature
analysis-based ML approaches have been shown to be successful
in different diagnostic applications, by explicitly defining a prior
set of features and processing steps28 (Fig. 1). Detection of HNC
can be achieved using these ML methods by obtaining clinically
important information from primary diagnostic imaging modal-
ities, in which high-dimensional, mineable images can be input to
train algorithms. For example, radiomic data can be derived from
radiographs, ultrasound (US), computed tomography (CT), mag-
netic resonance (MR), positron emission tomography (PET) and
nuclear medicine imaging methods, such as single-photon
emission computed tomography (SPECT). Similarly, histological,
cytological and immunohistochemical data can be obtained from
high-resolution whole-slide images (WSI) of stained tissue sections
from biopsies or surgical resections. Other emerging tools for non-
invasive detection of HNC include multispectral narrow-band
imaging, Raman spectroscopy, confocal laser endomicroscopy
(CLE) and infrared thermal imaging.
This paper seeks to provide an overview of the recently
published literature relating to the application of AI/ML methods
to aid diagnostic evaluation of HNC. An outline of the different
anatomical sites for HNC lesions, the type of diagnostic imaging
modality and the AI/ML method used will be presented.
METHODS
Literature search
Electronic database searches using MEDLINE via OVID, EMBASE
and Google Scholar were conducted to retrieve articles published
in the English language over the last eleven years (2009–2020).
This period was chosen due to the evolving application of AI/ML
methods in diagnostic cancer research over the last decade.
The search strategy was developed in collaboration with a
medical information specialist (Health Sciences Library, University
of Sheffield, UK) to ensure keywords were appropriately chosen
for optimal identification of articles. A combination of tailored
search strings containing database-specific medical subject head-
ings (MeSH) and controlled vocabulary was used (see Supplemen-
tary Information), and grey literature screened. Whilst not
intended as a formal systematic review, the recommendations
of the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement and checklist were followed where
possible.
Study selection
The selection criterion was jointly developed by the authorship
team. The principal inclusion criteria were studies applying AI/ML
methods to aid diagnosis of HNC using image analysis, with no
restrictions placed on the types of methods or imaging modalities
used. Due to the anticipated small number of studies in the field, a
broad range of studies such as those using AI/ML to identify or
differentiate between benign/pre-malignant/malignant pathol-
ogy, classify disease subtype, segment cancer regions or predict
disease outcome.
Studies using AI/ML to predict cancer susceptibility, metastasis,
recurrence, survival or treatment efficacy were not included in this
review. Studies focussing solely on the evaluation of oesophageal
or thyroid cancers were excluded, unless they were included as
part of a larger study that included other HNC lesions. Narrative
reviews, letters to editors, commentaries, conference abstracts and
animal studies were also excluded. All articles were independently
screened by two authors (H.M. and M.S.). The first screen involved
the assessment of study title and abstracts and the removal of
duplicate articles. The second screen involved comprehensive full-
text examination against the predefined criterion. In the case of
author discrepancy, two further authors (NMR, SAK) were
consulted to make a final decision on article inclusion.
Data capture and synthesis
Relevant data were extracted, tabulated and processed in





















Fig. 1 Feature extraction from primary diagnostic imaging modalities to train ML/DL algorithms to aid outcome prediction. Source: The
schematic diagrams were prepared in line with the journal’s artwork guidelines; the clinical/histological/radiological images were obtained
with appropriate consent from Sheffield Teaching Hospitals NHS Foundation Trust.
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● Study details (date of publication, authors, study location
and aims)
● Study methods (anatomical sites for HNC lesions, diagnostic
imaging modality, dataset sizes and application of AI/ML
methods to aid cancer diagnosis/outcome)
● AI/ML algorithm performance (reported accuracy measures)
A narrative synthesis with the relevant graphical display is
presented. Due to the variations in study outcomes and
heterogeneity of data, a meta-analysis for the calculation of
adjusted pool estimates was not performed.
RESULTS
The electronic database search retrieved 771 scientific articles.
After the removal of duplicates and screening of study titles and
abstracts, 698 articles were excluded. Detailed full-text examina-
tion of remaining articles excluded a further 41 studies, resulting
in 32 articles for inclusion (see Supplementary Table). Among the
selected articles, 9 were published between 2009 and 2014, and
the remaining 23 articles published between 2015 and 2020. The
primary outcomes of interest were anatomical sites of the HNC
lesions, diagnostic imaging modalities used for algorithm training/
optimisation and the type of AI/ML method.
Anatomical sites for HNC lesions
Figure 2 illustrates the different anatomical sites for the HNC
lesions in the selected studies, with the largest proportion
(16 studies) involving the oral cavity. Amongst these, nine studies
focussed on the assessment of oral squamous cell carcinoma
(OSCC) and seven studies focussed on the evaluation of, or
differentiation between, oral potentially malignant disorders
(OPMD) and OSCC. The remaining studies focussed on assessment
of nasopharyngeal SCC (n= 3),29–31 laryngeal SCC (n= 2),32,33
oropharyngeal SCC (n= 3),34–36 parotid gland neoplasms (n=
2)37,38 and differentiation between sinonasal SCC from inverted
papilloma (n= 1).39 In four studies,40–42 tissue sections of HNC
from various different sites (tongue, floor of mouth, soft palate,
mandible, gingivae, alveolar ridge, supraglottis, maxillary sinus,
nose, thyroid and parotid gland) were evaluated. One of these
studies did not specify the anatomical sites of the HNC lesions.43
Diagnostic imaging modalities for algorithm training/optimisation
Histology WSI of haematoxylin and eosin (H&E)-stained tissue
sections was used to train AI/ML algorithms in nine studies (Fig. 3).
Radiology image data were used in eight studies and obtained
from dynamic contrast-enhanced MRI (DCE-MRI) (n= 3),31,39,43 CT
(n= 2),36,37 PET/CT (n= 1),29 US (n= 1)38 and plain film intraoral
radiographs (n= 1).44 Other imaging modalities included hyper-
spectral imaging (HSI) (n= 6), endoscopic/clinical imaging (n= 5),
infrared thermal imaging (n= 1)45 and multimodal optical
imaging (n= 1).46 In the remaining two studies, clinicopathologic,
genomic and exfoliative cytological data were used to predict
outcomes based on traditional statistical analysis methods.47,48
Histology whole-slide imaging
In nine studies, histology WSI was used to develop algorithms for
evaluation of OSCC (n= 2),49,50 OPMD (n= 4),51–54 laryngeal SCC
(n= 1),32 oropharyngeal SCC (n= 1)35 and multiple HNC sites
(n= 1).55
These studies used a variety of different ML approaches to
delineate specific histological features of interest with down-
stream statistical analysis to compare differences in spatial
architectural patterns for differentiation between benign and
malignant lesions. ML tools were developed to assess differences
in detection of quantity, geometry, compactness and eccentricity
of sub-epithelial connective tissue cells and to identify textural
differences between normal and oral submucous fibrosis tissue
(with and without dysplasia or atrophy) using approaches
including Brownian motion.51–53
In one study, unsupervised ML methods were used for the
automated identification of tissue compartments in oropharyn-
geal SCC (OPSCC) tissue microarrays.35 Morphological measure-
ments of cell and nuclei were used for the classification of
epithelial and stromal tissue achieving a pixel-level F1 score of
80–81%. A further study showed that stimulated Raman scattering
histology integrated with DL algorithms provided the good
potential for delivering a rapid intraoperative diagnosis of
laryngeal SCC with an accuracy of 90%.32 Findings showed that
this method could identify tissue neoplasia at the simulated
resection margins that appear grossly normal with the naked eye,
highlighting the potential to enhance surgical resection and
reduce disease recurrence.
A recent systematic review highlights emerging evidence to
support the role of ML methods for histology images as a
potentially useful diagnostic aid for the detection of OSCC and
some OPMD, but identifies a lack of evidence for other head and
neck precancerous or cancerous lesions.44 However, the overall
quality of evidence in these studies is low, mainly due to the use
of small unicentric datasets and a high risk of bias that could have
overestimated model accuracy rates.
Radiological imaging
Three studies used radiomic-based feature prediction from MRI to
aid assessment of various HNC lesions,43 including nasopharyn-
geal31 and sinonasal SCC.39 Deng et al.43 proposed an automatic
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Fig. 2 HNC anatomical site distribution. A bar chart showing the
proportion of included studies based on head and neck cancer
anatomical subtype.













Fig. 3 Type of imaging modality/input data used. A pie chart
showing the proportion of identified studies based on the type of
maging modality/input data used to train AI/ML algorithms.
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evaluation of HNC lesions demonstrating superior segmentation
performance (area overlap measure of 0.76+ /−0.08 and accuracy
of 86 ± 8%), which outperformed previous similar studies. Huang
et al.31 evaluated the performance of two region-based segmen-
tation methods for the evaluation of nasopharyngeal SCC.
Ramkumar et al.39 found that MRI-based textural analysis had
the potential to differentiate sinonasal SCC from inverted
papilloma (accuracy 89.1%) with results comparable to manual
assessment by neuroradiologists (P= 0.0004).
Three studies used CT-based textural analysis for the evaluation
of HNC. Ajmi et al.37 developed an approach using spectral dual-
energy CT (DECT) data from multi-energy virtual monochromatic
image datasets to capture the energy-dependent changes in
tissue attenuation for the classification of common benign parotid
gland neoplasms (Warthin tumour and pleomorphic adenoma)
with an accuracy of 92%. Whereas Ranjbar et al.36 used CT-based
texture analysis to classify the HPV status of oropharyngeal SCC
(accuracy 75.7%). In another study, Wu et al.29 developed an
automated algorithm for the identification of nasopharyngeal SCC
on PET/CT examination with 100% accuracy for detection of
hypermetabolic lesions larger than 1 cm in size.
Only one study used textural features derived from an ultrasound
(US) using radio-frequency echo signals and image data to enable
automatic differentiation between malignant and benign parotid
gland lesions (accuracy 91%) based on a supervised classification
system.38 In another study, gravitational search-optimised echo-state
neural networks were developed for early prediction of OSCC from
intraoral X-rays with a detection accuracy of 99.2%.56
Endoscopic/clinical imaging
Four studies used clinical data from endoscopic imaging for the
detection of oral,57 nasopharyngeal,30 oropharyngeal34 and
laryngeal cancers.33 Amongst these, two studies employed DL
methods. The first study developed algorithms for early detection
of nasopharyngeal malignancies (accuracy of 88.7%)30 providing
surgeons with useful biopsy guidance. The second study
demonstrated the superior performance of DL compared to
textural feature-based ML methods (accuracy 88.3%, sensitivity
86.6% and specificity 90%) in recognition of sub-surface micro-
anatomical in vivo cell structures using confocal laser endomicro-
scopy (CLE) in OSCC patients.56
In two studies, traditional ML approaches were used for the
detection of oropharyngeal and laryngeal SCC. Mascharak et al.34
used multispectral narrow-band imaging and white-light endo-
scopy (WLE) to quantify the lymphoepithelial tissues of the
oropharynx. The results showed a promising ability to differentiate
between oropharyngeal SCC and healthy mucosa based on
differences in colour (accuracy 65.9% compared to 52.3% under
WLE, P= 0.0108), presumably a reflection of surface angiogenic
and local inflammatory changes. Whereas Moccia et al.33 used
traditional ML techniques to classify laryngeal tissues (normal vs
malignant) in narrow-band endoscopic images by exploiting
textural information (classification recall 93–98%). These studies
demonstrate a promising step towards an endoscope-based
processing system to support the early-stage diagnosis of HNC
lesions that may go unnoticed by the human eye.
Song et al.58 developed a smartphone-based intraoral dual-
modality imaging platform to classify OPMD and malignant
lesions based on autofluorescence and white-light images using
a convolutional neural network (CNN). The results demonstrated
an accuracy of ~86.9%, although the training sample was relatively
small (66 normal samples and 64 suspicious). Other limitations,
including training the CNN algorithms on tissue from different
anatomical regions (for normal, dysplastic and malignant tissues),
are likely to exhibit different autofluorescence characteristics due
to the varying tissue structural and biochemical compositions.
Other imaging modalities
Six studies used HSI for AI/ML training. Three of those studies
focussed on early detection and diagnosis of OSCC. Liu et al.59
used HSI to measure the reflectance spectra in the tongue to
enable differentiation between normal and cancerous tissue, with
a recognition rate of 96.5%. Roblyer et al.46 used multispectral
wide-field optical imaging—which included white-light reflec-
tance, autofluorescence, narrow-band reflectance and cross-
polarised imaging modalities—to distinguish between oral
cancer/precancer and non-neoplastic mucosa by evaluating image
contrast. Their results showed that autofluorescence imaging at
405-nm excitation wavelength provided the greatest image
contrast, and the ratio of red-to-green fluorescence intensity
computed from these images provided the best classification of
dysplasia/cancer versus non-neoplastic tissue (sensitivity of 100%,
specificity of 85%). Although this approach accurately distin-
guished malignant from benign tissue, the ability to separate
precancerous lesions from cancers was found to be limited. In the
third study, Quang et al.60 also used multimodal optical imaging,
in which autofluorescence imaging was used to identify high-risk
regions within the oral cavity, followed by high-resolution
microendoscopy to confirm or exclude the presence of neoplasia
(defined by the authors as diagnoses of moderate dysplasia or
worse). Data from 92 sites (n= 30) were used to develop
algorithms for the automatic identification of OSCC in vivo.
Diagnostic performance was evaluated prospectively using
images from 114 sites (n= 70) and the confirmed histological
diagnosis based on either a biopsy or an excised surgical
specimen. Amongst the sites that were biopsied (n= 56), the
classification accuracy for detection of benign and cancerous
lesions was 100 and 85%, respectively. Amongst the sites that
corresponded to a surgical specimen (n= 58), multimodal
imaging correctly classified 100% of benign and 61% of
neoplastic sites.
Jeyaraj et al.45 developed a convolutional neural network (CNN)
classifier for OSCC detection using multidimensional HSI (accuracy
of 91.4%). Similarly, Halicek et al.41 also developed a CNN classifier
that was trained using HSI of HNSCC surgical specimens, including
thyroid cancer, and normal head and neck tissue samples. This
model showed the potential to produce near-real-time automatic
tissue labelling for intraoperative cancer detection using HSI.
One study explored the viability of digital infrared thermal
imaging (DITI) for screening and detection of OSCC.61 DITI is a
non-invasive, non-ionising, radiation hazard-free modality that
essentially produces a heat map of an object by capturing its
radiated thermal energy. The authors developed a semi-
automated screening framework for OSCC by extracting signifi-
cantly discriminating textural features from facial thermograms for
classification into normal, precancerous or malignant categories
achieving an accuracy rate of 85.42%.
Another study developed diagnostic algorithms for HNSCC
detection using ML constructed by mass spectra obtained from
non-cancerous (n= 15, 114 mass spectra) and HNSCC (n= 19, 141
mass spectra) specimens by probe electrospray ionisation mass
spectrometry. The clinical validity of this approach was evaluated
to discriminate tumour-specific spectral patterns using intraopera-
tive specimens of HNSCC and normal mucosa with positive and
negative-ion modes showing accuracies in HNSCC diagnosis of
90.48% and 95.35%, respectively.
In another study,48 exfoliative cytology, histopathology and
clinical data of normal subjects (n= 102), oral leukoplakia (OLK)
patients (n= 82) and OSCC patients (n= 93) were collected for
quantitative risk stratification of OLK lesions. This involved expert-
guided data transformation and reconstruction for automatic data
processing to reveal a risk index for OSCC prediction (sensitivity:
median >0.98, specificity: median >0.99).
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Type of AI/ML method
Figure 4 illustrates the proportion of AI methods used in the
selected studies. Traditional ML methods were employed in
22 studies (69%) with common approaches, including Support
Vector Machine, Logistic Regression, Random Forest, Decision
Tree, K-Nearest Neighbour, Bayesian Classifier and Linear Dis-
criminant Analysis. DL-based neural networks were employed in
eight studies (25%), and a combination of traditional ML and DL
methods were used in two studies (6%).
Figure 5 provides a breakdown of the selected studies by
combining the anatomical site of lesion, imaging modality and AI
methods used in the recently published literature. Traditional ML
methods were most frequently used for the detection of precancer-
ous or cancerous lesions of the oral cavity (11 studies), and
specifically in studies using histology WSI (four studies). DL methods
were used for detection of HNSCC lesions of the oral cavity (five
studies), nasopharynx (one study), larynx (one study) and various
other head and neck sites as specified in a study by Halicek et al.41
DISCUSSION
This paper provides an insight into the recent application of AI/ML
for the evaluation of HNC lesions using digital image analysis. It has
shown, primarily, a wide breadth of imaging modalities that have
been used to retrieve input data for algorithm training in the last
decade. Whilst a detailed statistical analysis of the heterogeneous
dataset samples has not been undertaken, most studies have
indicated that ML can achieve high degrees of accuracy and
precision that can exceed the abilities of standard statistical
techniques and human judgement in making predictions about
data. This supports seminal claims made by Meehl in 1954,62 and
more recent meta-analyses,63,64 which propose that correctly used
mechanical (i.e., algorithmic) methods make more efficient
and reliable decisions and predictions about patient outcomes and
treatment. However, despite findings highlighted by our paper, very
few ML tools have actually been deployed into clinical practice.
Whilst a formal risk of bias analysis has not been conducted for the
cited studies, the reported accuracy rates should be interpreted with
caution. This is because most studies have used small unicentric
datasets that may be biased towards a particular patient demo-
graphics. Multi-centric research will inevitably allow a more diverse
dataset with the inclusion of patients from different geographical
locations, populations and demographics that will enhance algorithm








Fig. 4 Types of AI methods used. Proportion of studies using
traditional ML methods, modern deep learning methods and a
combination of both types of methods.
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Fig. 5 Overview of recently published literature. A diagram illustrating an overview of the recently published literature based on anatomical
site of lesion, imaging modality and AI methods used.
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Findings demonstrate the greatest proportion of studies to
have evaluated the detection of OPMD and cancerous lesions
within the oral cavity (Fig. 2) with histology WSI and radiological
imaging being the most frequently used modalities for algorithm
training (Fig. 3). This is consistent with the increasing ubiquity of
digital slide scanners in pathology laboratories and the emergence
of radiomics that has broadened the scope of routine medical
imaging in clinical oncology.
With the continued evolution of AI algorithms and computa-
tional power, a plethora of computational methods has been
developed for fast and reproducible diagnosis and prognosis of
HNC, as exemplified in this paper. The emergence of various high-
resolution imaging modalities (i.e., multimodal optical, microen-
doscopic, hyperspectral and infrared thermal) has provided an
unprecedented opportunity for quantitative feature extraction by
conversion into mineable images at relatively low cost and non-
invasively. Having said this, histology WSI remains the most
superior imaging modality for data leverage. This is because each
image provides multi-gigapixel-level information, thereby result-
ing in hundreds of thousands of sub-images (image patches) per
WSI for analysis and algorithm training.
Early work has been largely based on the development and
application of traditional ML methods (Fig. 4); however, in recent
years, the use of DL for HNSCC diagnosis and prognostication has
evolved. This opens the opportunity to develop state-of-the-art DL
techniques that can be combined with traditional approaches to
improve detection accuracy of head and neck precancerous and
cancerous lesions, as well as predict the course of a precancerous
or cancerous lesion learning from retrospective data. Another
exciting research avenue would be the development of new data
fusion algorithms that combine imaging modalities such as
radiologic, histologic and molecular measurements to aid disease
detection, classification and outcome prediction.
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